.jpg)
Epiminder’s implantable EEG system for epilepsy receives FDA authorisation
Epiminder has received FDA authorisation through the De Novo classification for its implantable continuous EEG monitoring system, Minder. The post Epiminder’s implantable EEG system for epilepsy receives FDA authorisation appeared first on Medical Device Network.
Epiminder has received FDA authorisation through the De Novo classification for its implantable continuous EEG monitoring system, Minder.
The post Epiminder’s implantable EEG system for epilepsy receives FDA authorisation appeared first on Medical Device Network.
